Bridgefront Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
2,058
+1,190
| +137% | +$625K | 0.29% | 80 |
|
|
2025
Q1 | $551K | Buy |
+868
| New | +$551K | 0.16% | 228 |
|
|
2024
Q4 | – | Sell |
-391
| Closed | -$411K | – | 751 |
|
|
2024
Q3 | $411K | Buy |
+391
| New | +$411K | 0.16% | 239 |
|
|
2023
Q3 | – | Sell |
-539
| Closed | -$387K | – | 570 |
|
|
2023
Q2 | $387K | Buy |
+539
| New | +$387K | 0.21% | 186 |
|
|
2021
Q3 | – | Sell |
-1,710
| Closed | -$955K | – | 609 |
|
|
2021
Q2 | $955K | Sell |
1,710
-110
| -6% | -$61.4K | 0.36% | 56 |
|
|
2021
Q1 | $861K | Buy |
1,820
+327
| +22% | +$155K | 0.27% | 79 |
|
|
2020
Q4 | $721K | Buy |
+1,493
| New | +$721K | 0.25% | 116 |
|